Sales Representative Radioligand Therapy📣 إعلان

About the Role

Novartis is seeking a Sales Representative to join their team in Riyadh, supporting the Radioligand Therapy portfolio. This full-time position focuses on engaging healthcare professionals to drive compliant and ethical sales growth within nuclear medicine pathways.

Key Responsibilities

• Identify, prioritize, and engage high-potential healthcare professionals and key stakeholders influencing treatment decisions to drive sales growth.
• Cultivate positive, customer-centric experiences through value-based conversations across in-person and virtual channels.
• Build trusted, long-term relationships with physicians, radio-pharmacists, nuclear technologists, medical physicists, opinion leaders, and other key medical influencers.
• Utilize customer insights, data, and feedback to develop and adjust territory, account, and engagement plans.
• Educate healthcare professionals on clinical value, patient identification and selection, and diagnostic and therapeutic workflows.
• Represent the Novartis Radioligand Therapy portfolio with key stakeholders involved in the treatment pathway.
• Support hospitals in the establishment or expansion of nuclear medicine centers.
• Collaborate compliantly with cross-functional teams to address unmet customer and patient needs.

Required Qualifications

• Saudi national.
• Minimum of two years of nuclear medicine technical experience in a hospital setting.
• Strong understanding of healthcare systems, hospital operations, and customer engagement within a clinical environment.
• Knowledge of nuclear medicine workflows and related diagnostic and therapeutic pathways.

Essential Skills and Attributes

• Strategic thinking with strong execution capability and the ability to translate insights into action.
• Excellent communication and relationship-building skills.
• A strong commitment to ethical and compliant ways of working.

Work Context

This is a full-time position based in Riyadh. The role involves direct engagement with healthcare professionals and stakeholders to advance the use of Radioligand Therapy.